Harvard Bioscience to attend Benchmark’s 8th Annual Discovery One-on-One Conference

HOLLISTON, Mass., Nov. 21, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), today announced that Jim Green, Chairman, President and CEO, and Michael Rossi, CFO will attend The Benchmark Company’s 8th Annual Discovery One-on-One Conference to be held on December 4, 2019 at the New York Athletic Club.

A copy of the materials to be presented at the conference will be available on the investor relations page of the Harvard Bioscience website on December 4, 2019.

About Harvard Bioscience

Harvard Bioscience is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Our customers range from renowned academic institutions and government laboratories, to the world’s leading pharmaceutical, biotechnology and clinical research organizations. With operations in North America and Europe, we sell through a combination of direct and distribution channels to customers around the world.

For more information, please visit our website at www.harvardbioscience.com.

Investor ContactMichael RossiChief Financial Officer(508) 893-8999[email protected]

You May Also Be Interested In

• The King Center and Divine Nine Launch Historic Fundraising Campaign to Preserve Critical History and Amplify Nonviolence365® Ahead of King100
• Dogecoin Price Prediction: $0.15 Bull Case Would More Than Double DOGE as AlphaPepe $1 Roadmap Talk Targets Bigger Upside
• Glitter Bug Gold Buyers Announces New Gold Seller Transparency Standard Across Orange County Locations